Opioids Aware: a general practice audit of high-dose opioid prescribing NHS England Midlands and East

Intended for Healthcare Professionals

Article Figures & Data

Table 1. Results of the audit

Patients, n	≥120 mg OME	≥120 mg OME for chronic pain	Drugs dose frequency	Indication	Overuse/misuse	Medication review last 3 months	Co-prescribing z drugs	Co-prescribing benzdiazepines	Co-prescribing gaba drugs	Gabapentin >3.6 g	Pregabalin >600 mg	Reflection
663 418	1022 (0.15% on high-dose opioids)	894 (0.13% on high-dose opioids for chronic pain;(894/1022 = 87.5% on high-dose for of chronic pain)	861 (96.3% clear)	593 (In 593/861 patients the indications is clear =68.9%; 31.1% not clear)	61 (61/894 = 6.8%)	429 (429/894 = 48.0%)	119 (119/894 =13.3%)	126 (126/894 = 14.1%)	379 (379/894 co-prescribed gaba drugs = 42.4%)	5 (5/894 on >3.6 g per day = 0.6%)	11 (11/894 on >600 mg pregabalin per day = 1.2%)	59 (59/74=80%)